SE8802805D0 - Pharmaceutical compositions promoting the wound healing and process for preparing same - Google Patents

Pharmaceutical compositions promoting the wound healing and process for preparing same

Info

Publication number
SE8802805D0
SE8802805D0 SE8802805A SE8802805A SE8802805D0 SE 8802805 D0 SE8802805 D0 SE 8802805D0 SE 8802805 A SE8802805 A SE 8802805A SE 8802805 A SE8802805 A SE 8802805A SE 8802805 D0 SE8802805 D0 SE 8802805D0
Authority
SE
Sweden
Prior art keywords
wound healing
pharmaceutical compositions
preparing same
compositions promoting
carrier
Prior art date
Application number
SE8802805A
Other languages
English (en)
Other versions
SE8802805L (sv
Inventor
J Balint
S Jancso
T Farago
J Erdei
I Kovacs
Z Emri
K Horvath
Original Assignee
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyogyszergyar filed Critical Biogal Gyogyszergyar
Publication of SE8802805D0 publication Critical patent/SE8802805D0/sv
Publication of SE8802805L publication Critical patent/SE8802805L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/436—Inhibitors, antagonists of receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE8802805A 1987-08-04 1988-08-03 Farmaceutisk komposition foer att underlaetta saarlaekning och foerfarande foer framstaellning av densamma SE8802805L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873554A HU201683B (en) 1987-08-04 1987-08-04 Process for producing pharmaceutical compositions for promoting healing of wounds

Publications (2)

Publication Number Publication Date
SE8802805D0 true SE8802805D0 (sv) 1988-08-03
SE8802805L SE8802805L (sv) 1989-02-05

Family

ID=10964527

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8802805A SE8802805L (sv) 1987-08-04 1988-08-03 Farmaceutisk komposition foer att underlaetta saarlaekning och foerfarande foer framstaellning av densamma

Country Status (16)

Country Link
JP (1) JPH01117828A (sv)
AU (1) AU612387B2 (sv)
BE (1) BE1001932A4 (sv)
BG (1) BG49522A1 (sv)
CH (1) CH675833A5 (sv)
CS (1) CS274600B2 (sv)
DD (1) DD272414A5 (sv)
DE (1) DE3826419A1 (sv)
ES (1) ES2007544A6 (sv)
FI (1) FI883638A (sv)
FR (1) FR2619011A1 (sv)
GB (1) GB2207865B (sv)
HU (1) HU201683B (sv)
IT (1) IT1226586B (sv)
NL (1) NL8801930A (sv)
SE (1) SE8802805L (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
IT1241521B (it) * 1990-07-31 1994-01-17 Polifarma Spa Impiego teperautico della ranitidina nella cura di ferite interessantila cute e i tessuti sottostanti
GB9102660D0 (en) * 1991-02-07 1991-03-27 Ultra Lab Ltd Wound dressing materials
DE4220736A1 (de) * 1992-06-25 1994-01-05 Puetter Medice Chem Pharm Einschlußkomplexe aus polymerisierten Cyclodextrinen mit pharmazeutisch aktiven Wirkstoffen
GB9424562D0 (en) 1994-12-06 1995-01-25 Giltech Ltd Product
DE9420259U1 (de) * 1994-12-17 1995-02-09 Röhm GmbH, 64293 Darmstadt Entbittertes Ranitidin-Präparat
TWI221768B (en) * 1996-08-16 2004-10-11 Schering Corp Pharmaceutical composition comprising histamine H1 receptor antagonist and histamine H3 receptor antagonist providing nasal decongestant effect
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
JP2001139477A (ja) * 1999-11-17 2001-05-22 Coherent Technology:Kk 創傷部位の組織細胞増殖促進液
DE10355085A1 (de) * 2003-11-24 2005-06-23 Schure, Frank, Dr. Wundverband
CN103816560B (zh) * 2014-03-03 2015-06-24 广西南宁博恩康生物科技有限公司 一种用于创口修复的胶体液及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE452109B (sv) * 1973-01-29 1987-11-16 Pharmacia Ab Rengoringsmedel for vetskande utvertes sarytor
US4747845A (en) * 1983-10-17 1988-05-31 Enquay Pharmaceutical Associates Synthetic resin matrix system for the extended delivery of drugs
US4668228A (en) * 1985-03-12 1987-05-26 Johnson & Johnson Products, Inc. Debriding tape
IE58373B1 (en) * 1986-06-18 1993-09-08 Bloomfield Frederick Jacob 5-Lipoxygenase pathway inhibitors

Also Published As

Publication number Publication date
CS274600B2 (en) 1991-08-13
BE1001932A4 (fr) 1990-04-17
HUT47848A (en) 1989-04-28
IT8821634A0 (it) 1988-08-03
SE8802805L (sv) 1989-02-05
DD272414A5 (de) 1989-10-11
AU2038788A (en) 1989-02-09
HU201683B (en) 1990-12-28
FI883638A (fi) 1989-02-05
AU612387B2 (en) 1991-07-11
NL8801930A (nl) 1989-03-01
GB2207865B (en) 1991-10-09
BG49522A1 (en) 1991-12-16
GB2207865A (en) 1989-02-15
CH675833A5 (sv) 1990-11-15
ES2007544A6 (es) 1989-06-16
JPH01117828A (ja) 1989-05-10
GB8818575D0 (en) 1988-09-07
FR2619011A1 (fr) 1989-02-10
DE3826419A1 (de) 1989-02-16
FI883638A0 (fi) 1988-08-03
CS543688A2 (en) 1990-10-12
IT1226586B (it) 1991-01-24

Similar Documents

Publication Publication Date Title
SE8702907D0 (sv) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
HUT46654A (en) Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient
ATE163849T1 (de) Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure
HUT48609A (en) Process for producing kumaran derivatives and pharmaceutical compositions comprising same as active ingredient
MD707C2 (ro) Derivaţi ai sulfonilureei, procedeu de obţinere a lor, produse intermediare pentru ei, substanţă pe baza lor cu acţiune erbicidă şi de reprimare a creşterii plantelor, procedeu de combatere a buruienilor
ATE72238T1 (de) Imidazoliumsalze, zwischenprodukte fuer ihre herstellung sowie ihre verwendung.
SE8802805D0 (sv) Pharmaceutical compositions promoting the wound healing and process for preparing same
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
HUT53897A (en) Process for producing benzopyran derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
AU586410B2 (en) New cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions
HUT54358A (en) Process for producing substituted 1,3,5-triazinetrione derivatives and medical compositions comprising such compounds as active ingredient
HUT63151A (en) Process for producing new benzimidazole-2-sulfonamide and imidazopyuridine-2-sylfonamide derivatives, as well as pharmaceutical compositions comprising same as active ingredient
PT85766A (en) Process for the preparation of pharmaceutical compounds to wound-healing containing 1-(bicyclic heterocyclil-alkyl)-pyperidine heterocyclil derivatives and wound coating products therewith
ATE55985T1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
FR2567402B1 (fr) Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
SE8704049D0 (sv) Novel pharmacological compounds
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8802805-5

Effective date: 19930301

Format of ref document f/p: F